Monoisopropanolamine (MIPA) Market Statistics – 2030

The global monoisopropanolamine (MIPA) market was valued at $82.2 million in 2020, and is projected to reach $140.8 million by 2030, growing at a CAGR of 5.6% from 2021 to 2030. Monoisopropanolamine (MIPA also known as isopropanolamine is an organic compound that is used as an acidic herbicide neutralizer, pH regulator, and reactive agent. 

[COVIDIMPACTSTATEMENT]

Use of monoisopropanolamine for neutralizing fatty acid chemical compounds and sulfonic acid-based surfactants is the key market trend. In addition, MIPA based chemical compounds improve color & heat stability and improve oil solubility as compared with ethanolamine. This in turn has surged the use of MIPA in chemical industry for production of buffer and alkaline chemicals. Other use of MIPA includes production of reactive & processing agents, corrosion inhibitors, pH regulators, and pigment dispersants. All these factors are driving its demand in the global market. In addition, use of monoisopropanolamine for formulation of cosmetic products, shaving creams, and mascara is the key market trend. Baby shampoo products and bubble bathing products are another example that uses MIPA during their formulation. MIPA is also used during production of hair color products, hair bleaching products, and other skin care products, which is driving the adoption of MIPA in personal care industry. All these factors collectively surge the demand for monoisopropanolamine (MIPA), thereby augmenting the global market growth.

Get more information on this report : Request Sample Pages

However, monoisopropanolamine (MIPA) if exposed beyond the maximum concentration levels may cause irritation and burn in eyes and skin. Moreover, breathing monoisopropanolamine can irritate the nose and throat causing coughing and wheezing. Furthermore, its open discharge may cause severe skin and eye irritation in rabbits, whilst nasal and lung irritation in other animals. In addition to this, several cases of dermatitis have been registered among the workforce dealing with monoisopropanolamine. These factors restrain the demand for monoisopropanolamine among various end-use industries. Also, several environmental agencies such as the U.S. Environmental Protection Agency (U.S. EPA), Central Pollution Control Board (CPCB), European Union (EU), and others, have laid down acts and regulations for handling and use of monoisopropanolamine, which is expected to hamper the market growth during the forecast period. 

On the contrary, the increasing R&D activities have surged the potential applications of monoisopropanolamine in several end-use sectors. For instance, chemical industry has started using monoisopropanolamine for solubilizing & neutralizing fatty acids and sulfonic acid-based surfactants. Moreover, it is widely used as an emulsifier in producing weather resistant coatings. Also, it is widely adopted as corrosion inhibitor in various industries such as metals & metallurgy, oil & gas, chemical manufacturing, and others. In addition to this, it is used as emulsifiers, dispersants, and wetting agents in a wide array of applications, including gas purification, cement and concrete processing aids, cosmetic formulations, metalworking fluids, and others. Furthermore, monoisopropanolamine has given excellent results in synthesis of various drugs at very low cost. These factors are anticipated to increase the sales of monoisopropanolamine in several end-use sectors; thus, creating lucrative opportunities for the market. 

The monoisopropanolamine (MIPA) market is segmented on the basis of end-use industry and region. By end-use industry, the global monoisopropanolamine market is divided into chemical industry, personal care, agrochemical, pharmaceuticals, metalworking, and others. Region wise, the market is studied across North America, Europe, Asia-Pacific, and LAMEA. 

Monoisopropanolamine (MIPA) market, by region

The Asia-Pacific monoisopropanolamine market accounted for 54.4% of the market share in 2020, and is projected to grow at the highest CAGR of 6.3% during the forecast period. Rise in agriculture, metal working, personal care, and chemical manufacturing sectors have enhanced the performance of monoisopropanolamine in the Asia-Pacific region. China's metalworking sector is increasing rapidly, which has forced the manufacturers to produce high-quality monoisopropanolamine in the region. Moreover, the personal care & cosmetics industry in India has witnessed a rapid surge in demand, where monoisopropanolamine is widely used in manufacturing various cosmetic products. For instance, according to a report published by India Brands Equity Foundation, India’s beauty, cosmetic and grooming market is projected to reach $20 billion by 2025.

[REGIONGRAPH]

Monoisopropanolamine (MIPA) market, by end-use industry

In 2020, the chemical end-use industry was the largest revenue generator, and is anticipated to grow at a CAGR of 5.7% during the forecast period. MIPA based chemical compounds improve color & heat stability and improve oil solubility as compared to ethanolamine. This in turn has surged the use of MIPA in chemical industry for production of buffer and alkaline chemicals. Other uses of MIPA include production of reactive & processing agents, corrosion inhibitors, pH regulators, and pigment dispersants. All these factors are driving the demand of the global market. MIPA is also used in production of LCD and paint strippers, reaction intermediate products, and waterborne coatings is a considerable factor that is expected to offer new growth opportunities during the forecast period.

[ENDUSEINDUSTRYGRAPH]

Key benefits for stakeholders

• Porter’s five forces analysis helps analyze the potential of buyers & suppliers and the competitive scenario of the industry for strategy building.
• It outlines the current market trends and future estimations of global monoisopropanolamine (MIPA) market from 2020 to 2030 to understand the prevailing opportunities and potential investment pockets.
• The major countries in the region have been mapped according to their individual revenue contribution to the regional market.
• The key drivers, restraints, and opportunities and their detailed impact analysis are explained in the study.
• The profiles of key players and their key strategic developments are enlisted in the report.

Impact Of Covid-19 On The Global Monoisopropanolamine (Mipa) Market

• The novel coronavirus is an incomparable global pandemic that has spread to over 180 countries and caused huge losses of lives and the economy around the globe. The monoisopropanolamine (MIPA) market has been negatively impacted due to the wake of the COVID-19 pandemic, owing to its dependence on chemical manufacturing, metalworking, cosmetics, and other end-use sectors. For instance, according to a report published by the American Chemistry Council (ACC), the U.S. chemical output fell by 3.6% in 2020 after a 0.1% dip in 2019. Furthermore, to control the surge of novel coronavirus cases, there is a drastic shift of investments from other sectors toward healthcare. 
• Also, several monoisopropanolamine manufacturing companies have either shut down or shrank their operations, due to the risk of infection among the workforce. This has temporarily hampered the production rate of the monoisopropanolamine (MIPA) market. 
• In addition, the falling income of customers has led contraction in the demand for cosmetic products where monoisopropanolamine is widely used as an intermediate in producing various cosmetics & beauty care products. Furthermore, the industry has faced various problems related to transportation, the non-availability of a skilled workforce, and reduced export/import orders amid the COVID-19 period. This has led the monoisopropanolamine (MIPA) market to witness a downfall in demand. 
• However, the emerging applications of monoisopropanolamine for synthesis of various drugs in the pharmaceutical sector may lead the monoisopropanolamine (MIPA) market to recover post COVID-19 scenario. For instance, according to an article published by the Business Standard, the second wave of COVID has pushed the growth of the Indian pharmaceutical industry to 59% in April 2020. 
• Furthermore, increasing applications of monoisopropanolamine in agrochemical sector for manufacturing various herbicides may lead the monoisopropanolamine (MIPA) market to witness a significant growth in demand. For instance, according to an economic survey conducted by the Indian Ministry of Finance, the agriculture and allied activities in India clocked a growth of 3.4% during 2020-21. In addition to this, as the restrictions imposed due to lockdowns are being lifted, the monoisopropanolamine manufacturing sector is expected to recover soon, owing to an increase in demand for personal care & cosmetics, agrochemicals, and chemical intermediates in both developed and developing economies. 

 Key Market Segments

• By END-USE INDUSTRY
  • Chemical industry
  • Personal care
  • Agrochemical
  • Pharmaceuticals
  • Metal working
  • Others
• By Region
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Europe
    • France
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

 
Key Market Players

• ACETO
• EASTMAN CHEMICAL COMPANY
• LANXESS
• BASF SE
• HANGZHOU LINGRUI CHEMICAL CO., LTD
• ORION CHEM PVT. LTD.
• MUBY CHEMICALS
• SASOL
• ANHUI SINOTECH INDUSTRIAL CO., LTD., LTD.
• ZHEJIANG XINHUA CHEMICAL CO., LTD
• HONGBAOLI GROUP CO., LTD
• THE DOW CHEMICAL COMPANY
• ALKYL AMINES CHEMICALS LIMITED
• OQ SAOC
• ARKEMA S.A.

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research

1.5.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis
3.4.Market dynamics

3.4.1.Drivers

3.4.1.1.Increase in demand from agricultural sector
3.4.1.2.Rise in use of monoisopropanolamine in personal care and cosmetic end-use industry

3.4.2.Restraint

3.4.2.1.Toxicity of monoisopropanolamine

3.4.3.Opportunity

3.4.3.1.Emerging application of monoisopropanolamine

3.5.Value chain analysis
3.6.Pricing analysis
3.7.Impact of key regulations on the global monoisopropanolamine (MIPA) market
3.8.Impact of COVID-19 on the global monoisopropanolamine (MIPA) market
3.9.Patent analysis, 2012-2021

CHAPTER 4:MONOISOPROPANOLAMINE (MIPA) MARKET, BY END-USE INDUSTRY

4.1.Overview

4.1.1.Market size and forecast, by end-use industry

4.2.Chemical industry

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market share analysis, by country

4.3.Personal care

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market share analysis, by country

4.4.Agrochemical

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market share analysis, by country

4.5.Pharmaceuticals

4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by region
4.5.3.Market share analysis, by country

4.6.Metal working

4.6.1.Key market trends, growth factors, and opportunities
4.6.2.Market size and forecast, by region
4.6.3.Market share analysis, by country

4.7.Others

4.7.1.Key market trends, growth factors, and opportunities
4.7.2.Market size and forecast, by region
4.7.3.Market share analysis, by country

CHAPTER 5:MONOISOPROPANOLAMINE MARKET, BY REGION

5.1.Overview

5.1.1.Market size and forecast

5.2.North America

5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by end-use industry
5.2.3.Market share analysis, by country

5.2.3.1.U.S.

5.2.3.1.1.Market size and forecast, by end-use industry

5.2.3.2.Canada

5.2.3.2.1.Market size and forecast, by end-use industry

5.2.3.3.Mexico

5.2.3.3.1.Market size and forecast, by end-use industry

5.3.Europe

5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by end-use industry
5.3.3.Market share analysis, by country

5.3.3.1.Germany

5.3.3.1.1.Market size and forecast, by end-use industry

5.3.3.2.France

5.3.3.2.1.Market size and forecast, by end-use industry

5.3.3.3.Italy

5.3.3.3.1.Market size and forecast, by end-use industry

5.3.3.4.Spain

5.3.3.4.1.Market size and forecast, by end-use industry

5.3.3.5.UK

5.3.3.5.1.Market size and forecast, by end-use industry

5.3.3.6.Rest of Europe

5.3.3.6.1.Market size and forecast, by end-use industry

5.4.Asia-Pacific

5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by end-use industry
5.4.3.Market share analysis, by country

5.4.3.1.China

5.4.3.1.1.Market size and forecast, by end-use industry

5.4.3.2.Japan

5.4.3.2.1.Market size and forecast, by end-use industry

5.4.3.3.India

5.4.3.3.1.Market size and forecast, by end-use industry

5.4.3.4.South Korea

5.4.3.4.1.Market size and forecast, by end-use industry

5.4.3.5.Australia

5.4.3.5.1.Market size and forecast, by end-use industry

5.4.3.6.Rest of Asia-Pacific

5.4.3.6.1.Market size and forecast, by end-use industry

5.5.LAMEA

5.5.1.Key market trends, growth factors, and opportunities
5.5.2.Market size and forecast, by end-use industry
5.5.3.Market share analysis, by country

5.5.3.1.Brazil

5.5.3.1.1.Market size and forecast, by end-use industry

5.5.3.2.Saudi Arabia

5.5.3.2.1.Market size and forecast, by end-use industry

5.5.3.3.South Africa

5.5.3.3.1.Market size and forecast, by end-use industry

5.5.3.4.Rest of LAMEA

5.5.3.4.1.Market size and forecast, by end-use industry

CHAPTER 6:COMPETITIVE LANDSCAPE

6.1.Introduction

6.1.1.Market player positioning, 2020

6.2.Product mapping of top 10 player
6.3.Competitive heatmap

CHAPTER 7:COMPANY PROFILES

7.1.ACETO

7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Product portfolio

7.2.ALKYL AMINES CHEMICALS LIMITED

7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.2.5.Business performance

7.3.ANHUI SINOTECH INDUSTRIAL CO., LTD.

7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Product portfolio

7.4.ARKEMA S.A.

7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.4.5.Business performance

7.5.BASF SE

7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments
7.5.4.Product portfolio
7.5.5.Business performance

7.6.EASTMAN CHEMICAL COMPANY

7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio
7.6.5.Business performance

7.7.HANGZHOU LINGRUI CHEMICAL CO., LTD

7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Product portfolio

7.8.HONGBAOLI GROUP CO., LTD

7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Product portfolio

7.9.LANXESS

7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments
7.9.4.Product portfolio
7.9.5.Business performance

7.10.MUBY CHEMICALS

7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Product portfolio

7.11.ORION CHEM PVT. LTD.

7.11.1.Company overview
7.11.2.Company snapshot
7.11.3.Product portfolio

7.12.OQ SAOC

7.12.1.Company overview
7.12.2.Company snapshot
7.12.3.Product portfolio
7.12.4.Business performance

7.13.SASOL

7.13.1.Company overview
7.13.2.Company snapshot
7.13.3.Operating business segments
7.13.4.Product portfolio
7.13.5.Business performance

7.14.THE DOW CHEMICAL COMPANY

7.14.1.Company overview
7.14.2.Company snapshot
7.14.3.Operating business segments
7.14.4.Product portfolio
7.14.5.Business performance

7.15.ZHEJIANG XINHUA CHEMICAL CO., LTD.

7.15.1.Company overview
7.15.2.Company snapshot
7.15.3.Product portfolio

LIST OF TABLES

TABLE 01.MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020-2030 ($MILLION)
TABLE 02.MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020-2030 (TONS)
TABLE 03.MONOISOPROPANOLAMINE MARKET FOR CHEMICAL INDUSTRY, BY REGION, 2020–2030 ($MILLION)
TABLE 04.MONOISOPROPANOLAMINE MARKET FOR CHEMICAL INDUSTRY, BY REGION, 2020–2030 (TONS)
TABLE 05.MONOISOPROPANOLAMINE MARKET FOR PERSONAL CARE END-USE INDUSTRY, BY REGION, 2020–2030 ($MILLION)
TABLE 06.MONOISOPROPANOLAMINE MARKET FOR PERSONAL CARE END-USE INDUSTRY, BY REGION, 2020–2030 (TONS)
TABLE 07.MONOISOPROPANOLAMINE MARKET FOR AGROCHEMICAL END-USE INDUSTRY, BY REGION, 2020–2030 ($MILLION)
TABLE 08.MONOISOPROPANOLAMINE MARKET FOR AGROCHEMICAL END-USE INDUSTRY, BY REGION, 2020–2030 (TONS)
TABLE 09.MONOISOPROPANOLAMINE MARKET FOR PHARMACEUTICALS END-USE INDUSTRY, BY REGION, 2020–2030 ($MILLION)
TABLE 10.MONOISOPROPANOLAMINE MARKET FOR PHARMACEUTICALS END-USE INDUSTRY, BY REGION, 2020–2030 (TONS)
TABLE 11.MONOISOPROPANOLAMINE MARKET FOR METAL WORKING END-USE INDUSTRY, BY REGION, 2020–2030 ($MILLION)
TABLE 12.MONOISOPROPANOLAMINE MARKET FOR METAL WORKING END-USE INDUSTRY, BY REGION, 2020–2030 (TONS)
TABLE 13.MONOISOPROPANOLAMINE MARKET FOR OTHERS END-USE INDUSTRY, BY REGION, 2020–2030 ($MILLION)
TABLE 14.MONOISOPROPANOLAMINE MARKET FOR OTHERS END-USE INDUSTRY, BY REGION, 2020–2030 (TONS)
TABLE 15.MONOISOPROPANOLAMINE MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 16.MONOISOPROPANOLAMINE MARKET, BY REGION, 2020–2030 (TONS)
TABLE 17.NORTH AMERICA MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 ($MILLION)
TABLE 18.NORTH AMERICA MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 (TONS)
TABLE 19.NORTH AMERICA MONOISOPROPANOLAMINE MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 20.NORTH AMERICA MONOISOPROPANOLAMINE MARKET, BY COUNTRY, 2020–2030 (TONS)
TABLE 21.U.S. MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 ($MILLION)
TABLE 22.U.S. MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 (TONS)
TABLE 23.CANADA MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 ($MILLION)
TABLE 24.CANADA MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 (TONS)
TABLE 25.MEXICO MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 ($MILLION)
TABLE 26.MEXICO MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 (TONS)
TABLE 27.EUROPE MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 ($MILLION)
TABLE 28.EUROPE MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 (TONS)
TABLE 29.EUROPE MONOISOPROPANOLAMINE MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 30.EUROPE MONOISOPROPANOLAMINE MARKET, BY COUNTRY, 2020–2030 (TONS)
TABLE 31.GERMANY MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 ($MILLION)
TABLE 32.GERMANY MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 (TONS)
TABLE 33.FRANCE MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 ($MILLION)
TABLE 34.FRANCE MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 (TONS)
TABLE 35.ITALY MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 ($MILLION)
TABLE 36.ITALY MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 (TONS)
TABLE 37.SPAIN MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 ($MILLION)
TABLE 38.SPAIN MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 (TONS)
TABLE 39.UK MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 ($MILLION)
TABLE 40.UK MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 (TONS)
TABLE 41.REST OF EUROPE MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 ($MILLION)
TABLE 42.REST OF EUROPE MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 (TONS)
TABLE 43.ASIA-PACIFIC MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 ($MILLION)
TABLE 44.ASIA-PACIFIC MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 (TONS)
TABLE 45.ASIA-PACIFIC MONOISOPROPANOLAMINE MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 46.ASIA-PACIFIC MONOISOPROPANOLAMINE MARKET, BY COUNTRY, 2020–2030 (TONS)
TABLE 47.CHINA MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 ($MILLION)
TABLE 48.CHINA MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 (TONS)
TABLE 49.JAPAN MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 ($MILLION)
TABLE 50.JAPAN MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 (TONS)
TABLE 51.INDIA MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 ($MILLION)
TABLE 52.INDIA MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 (TONS)
TABLE 53.SOUTH KOREA MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 ($MILLION)
TABLE 54.SOUTH KOREA MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 (TONS)
TABLE 55.AUSTRALIA MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 ($MILLION)
TABLE 56.AUSTRALIA MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 (TONS)
TABLE 57.REST OF ASIA-PACIFIC MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 ($MILLION)
TABLE 58.REST OF ASIA-PACIFIC MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 (TONS)
TABLE 59.LAMEA MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 ($MILLION)
TABLE 60.LAMEA MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 (TONS)
TABLE 61.LAMEA MONOISOPROPANOLAMINE MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 62.LAMEA MONOISOPROPANOLAMINE MARKET, BY COUNTRY, 2020–2030 (TONS)
TABLE 63.BRAZIL MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 ($MILLION)
TABLE 64.BRAZIL MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 (TONS)
TABLE 65.SAUDI ARABIA MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 ($MILLION)
TABLE 66.SAUDI ARABIA MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 (TONS)
TABLE 67.SOUTH AFRICA MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 ($MILLION)
TABLE 68.SOUTH AFRICA MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 (TONS)
TABLE 69.REST OF LAMEA MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 ($MILLION)
TABLE 70.REST OF LAMEA MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 (TONS)
TABLE 71.ACETO: COMPANY SNAPSHOT
TABLE 72.ACETO: PRODUCT PORTFOLIO
TABLE 73.ALKYL AMINES CHEMICALS: COMPANY SNAPSHOT
TABLE 74.ALKYL AMINES CHEMICALS LIMITED: OPERATING SEGMENTS
TABLE 75.ALKYL AMINES CHEMICALS LIMITED: PRODUCT PORTFOLIO
TABLE 76.OVERALL FINANCIAL STATUS ($MILLION)
TABLE 77.ANHUI SINOTECH INDUSTRIAL CO. LTD.: COMPANY SNAPSHOT
TABLE 78.ANHUI SINOTECH INDUSTRIAL CO. LTD.: PRODUCT PORTFOLIO
TABLE 79.ARKEMA S.A.: COMPANY SNAPSHOT
TABLE 80.ARKEMA S.A.: OPERATING SEGMENTS
TABLE 81.ARKEMA S.A.: PRODUCT PORTFOLIO
TABLE 82.OVERALL FINANCIAL STATUS ($MILLION)
TABLE 83.BASF SE: COMPANY SNAPSHOT
TABLE 84.BASF SE: OPERATING SEGMENT
TABLE 85.BASF SE: PRODUCT PORTFOLIO
TABLE 86.OVERALL FINANCIAL STATUS ($BILLION)
TABLE 87.EASTMAN CHEMICAL COMPANY: COMPANY SNAPSHOT
TABLE 88.EASTMAN CHEMICAL COMPANY: OPERATING SEGMENTS
TABLE 89.EASTMAN CHEMICAL COMPANY:PRODUCT PORTFOLIO
TABLE 90.OVERALL FINANCIAL STATUS ($BILLION)
TABLE 91.HANGZHOU LINGRUI CHEMICAL CO., LTD.: COMPANY SNAPSHOT
TABLE 92.HANGZHOU LINGRUI CHEMICAL CO., LTD.: PRODUCT PORTFOLIO
TABLE 93.HONGBAOLI GROUP CO. LTD.: COMPANY SNAPSHOT
TABLE 94.HONGBAOLI GROUP CO. LTD.: PRODUCT PORTFOLIO
TABLE 95.LANXESS : COMPANY SNAPSHOT
TABLE 96.LANXESS: OPERATING SEGMENTS
TABLE 97.LANXESS: PRODUCT PORTFOLIO
TABLE 98.OVERALL FINANCIAL STATUS ($MILLION)
TABLE 99.MUBY CHEMICALS: COMPANY SNAPSHOT
TABLE 100.MUBY CHEMICALS: PRODUCT PORTFOLIO
TABLE 101.ORION CHEM PVT. LTD.: COMPANY SNAPSHOT
TABLE 102.ORION CHEM PVT. LTD.: PRODUCT PORTFOLIO
TABLE 103.OQ SAOC: COMPANY SNAPSHOT
TABLE 104.OQ SAOC: PRODUCT PORTFOLIO
TABLE 105.OVERALL FINANCIAL STATUS ($MILLION)
TABLE 106.SASOL: COMPANY SNAPSHOT
TABLE 107.SASOL: OPERATING SEGMENTS
TABLE 108.SASOL: PRODUCT PORTFOLIO
TABLE 109.OVERALL FINANCIAL STATUS ($MILLION)
TABLE 110.DOW: COMPANY SNAPSHOT
TABLE 111.DOW: OPERATING SEGMENTS
TABLE 112.DOW: PRODUCT PORTFOLIO
TABLE 113.OVERALL FINANCIAL STATUS ($MILLION)
TABLE 114.ZHEJIANG XINHUA CHEMICAL CO., LTD.: COMPANY SNAPSHOT
TABLE 115.ZHEJIANG XINHUA CHEMICAL CO., LTD.: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.MONOISOPROPANOLAMINE (MIPA) MARKET SNAPSHOT
FIGURE 02.MONOISOPROPANOLAMINE (MIPA) MARKET SEGMENTATION
FIGURE 03.TOP INVESTMENT POCKETS
FIGURE 04.HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 05.MODERATE BARGAINING POWER OF BUYERS
FIGURE 06.MODERATE THREAT OF NEW ENTRANTS
FIGURE 07.MODERATE THREAT OF SUBSTITUTES
FIGURE 08.MODERATE COMPETITIVE RIVALRY
FIGURE 09.MONOISOPROPANOLAMINE (MIPA) MARKET DYNAMICS
FIGURE 10.VALUE CHAIN ANALYSIS
FIGURE 11.MONOISOPROPANOLAMINE (MIPA) MARKET, PRICING ANALYSIS, BY END-USE INDUSTRY, USD/TON
FIGURE 12.PATENT ANALYSIS, BY COUNTRY, 2012-2021
FIGURE 13.PATENT ANALYSIS, BY APPLICANT, 2012-2021
FIGURE 14.PATENT ANALYSIS, BY PUBLICATION DATE, 2012-2021
FIGURE 15.MONOISOPROPANOLAMINE MARKET, BY END-USE INDUSTRY, 2020–2030 ($MILILION)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF MONOISOPROPANOLAMINE MARKET FOR CHEMICAL INDUSTRY, BY COUNTRY, 2020 & 2030 (%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF MONOISOPROPANOLAMINE MARKET FOR PERSONAL CARE END-USE INDUSTRY, BY COUNTRY, 2020 & 2030 (%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF MONOISOPROPANOLAMINE MARKET FOR AGROCHEMICAL END-USE INDUSTRY, BY COUNTRY, 2020 & 2030 (%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF MONOISOPROPANOLAMINE MARKET FOR PHARMACEUTICALS END-USE INDUSTRY, BY COUNTRY, 2020 & 2030 (%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF MONOISOPROPANOLAMINE MARKET FOR METAL WORKING END-USE INDUSTRY, BY COUNTRY, 2020 & 2030 (%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF MONOISOPROPANOLAMINE MARKET FOR OTHERS END-USE INDUSTRY, BY COUNTRY, 2020 & 2030 (%)
FIGURE 22.MONOISOPROPANOLAMINE MARKET, BY REGION, 2020–2030 ($ MILLION)
FIGURE 23.U.S. MONOISOPROPANOLAMINE MARKET REVENUE, 2020–2030($MILLION)
FIGURE 24.CANADA MONOISOPROPANOLAMINE MARKET REVENUE, 2020–2030($MILLION)
FIGURE 25.MEXICO MONOISOPROPANOLAMINE MARKET REVENUE, 2020–2030($MILLION)
FIGURE 26.GERMANY MONOISOPROPANOLAMINE MARKET REVENUE, 2020–2030($MILLION)
FIGURE 27.FRANCE MONOISOPROPANOLAMINE MARKET REVENUE, 2020–2030($MILLION)
FIGURE 28.ITALY MONOISOPROPANOLAMINE MARKET REVENUE, 2020–2030($MILLION)
FIGURE 29.SPAIN MONOISOPROPANOLAMINE MARKET REVENUE, 2020–2030($MILLION)
FIGURE 30.UK MONOISOPROPANOLAMINE MARKET REVENUE, 2020–2030($MILLION)
FIGURE 31.REST OF EUROPE MONOISOPROPANOLAMINE MARKET REVENUE, 2020–2030($MILLION)
FIGURE 32.CHINA MONOISOPROPANOLAMINE MARKET REVENUE, 2020–2030($MILLION)
FIGURE 33.JAPAN MONOISOPROPANOLAMINE MARKET REVENUE, 2020–2030($MILLION)
FIGURE 34.INDIA MONOISOPROPANOLAMINE MARKET REVENUE, 2020–2030($MILLION)
FIGURE 35.SOUTH KOREA MONOISOPROPANOLAMINE MARKET REVENUE, 2020–2030($MILLION)
FIGURE 36.AUSTRALIA MONOISOPROPANOLAMINE MARKET REVENUE, 2020–2030($MILLION)
FIGURE 37.REST OF ASIA-PACIFIC MONOISOPROPANOLAMINE MARKET REVENUE, 2020–2030($MILLION)
FIGURE 38.BRAZIL MONOISOPROPANOLAMINE MARKET REVENUE, 2020–2030($MILLION)
FIGURE 39.SAUDI ARABIA MONOISOPROPANOLAMINE MARKET REVENUE, 2020–2030($MILLION)
FIGURE 40.SOUTH AFRICA MONOISOPROPANOLAMINE MARKET REVENUE, 2020–2030($MILLION)
FIGURE 41.REST OF LAMEA MONOISOPROPANOLAMINE MARKET REVENUE, 2020–2030($MILLION)
FIGURE 42.MARKET PLAYER POSITIONING, 2020
FIGURE 43.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 44.COMPETITIVE HEATMAP OF KEY PLAYERS
FIGURE 45.ALKYL AMINES CHEMICALS LIMITED: REVENUE, 2019–2021 ($MILLION)
FIGURE 46.ALKYL AMINES CHEMICALS LIMITED: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 47.ARKEMA S.A.: REVENUE, 2018-2020 ($MILLION)
FIGURE 48.ARKEMA S.A.: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 49.ARKEMA S.A.: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 50.BASF SE: REVENUE, 2018–2020 ($BILLION)
FIGURE 51.BASF SE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 52.BASF SE: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 53.EASTMAN CHEMICAL COMPANY: REVENUE, 2018-2020 ($BILLION)
FIGURE 54.EASTMAN CHEMICAL COMPANY: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 55.EASTMAN CHEMICAL COMPANY: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 56.LANXESS: REVENUE, 2018–2020 ($MILLION)
FIGURE 57.LANXESS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 58.LANXESS: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 59.OQ SAOC: REVENUE, 2019–2020 ($MILLION)
FIGURE 60.SASOL: REVENUE, 2019–2021 ($MILLION)
FIGURE 61.SASOL: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 62.SASOL: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 63.DOW: REVENUE, 2018–2020 ($MILLION)
FIGURE 64.DOW: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 65.DOW: REVENUE SHARE BY REGION, 2020 (%)